The Journal of Organic Chemistry
Article
N2,N2-Dioctyl-N5-phenylpyrimidine-2,5-diamine (2). Yield: 4.6 g,
89%. Yellow oil. Mobile phase for purification: 40% Et2O/hexanes
with 3% Et3N. H NMR (400 MHz, DMSO-d6) δ 8.19 (s, 2H), 7.52
(s, 1H), 7.11 (dd, J = 8.5, 7.2 Hz, 2H), 6.70 (dt, J = 7.7, 1.1 Hz, 2H),
6.68−6.63 (m, 1H), 3.54−3.43 (m, 4H), 1.54 (t, J = 7.2 Hz, 4H),
1.34−1.15 (m, 21H), 0.89−0.81 (m, 6H). 13C{H} NMR (101 MHz,
DMSO-d6) δ 158.4, 153.6, 147.0, 129.6, 126.4, 118.2, 113.7, 47.7,
31.6, 29.3, 29.1, 27.7, 26.8, 22.5, 14.4. HRMS (EI) m/z: [M]+ calcd
for C26H42N4 410.3409; found 410.3390.
2H), 6.65 (d, J = 8.5 Hz, 2H), 3.49 (t, J = 7.4 4H), 1.58−1.48 (m,
4H), 1.27−1.45 (m, 20H), 0.87 (t, J = 6.72 Hz, 6H). 13C{H} NMR
(101 MHz, DMSO-d6) δ 157.8, 152.4, 144.0, 129.6, 126.6, 126.3,
113.7, 47.2, 31.2, 28.8, 28.7, 27.3, 26.4, 22.1, 13.9. HRMS (EI) m/z:
[M]+ calcd for C27H41D3N4 427.3754; found, 427.3779.
Inhibited Autoxidation of 1,4-Dioxane at 37 °C. A 3.5 mL
quartz cuvette was loaded with unstabilized 1,4-dioxane (0.625 mL)
along with PhCl (1.805 mL). The cuvette was then preheated to 37
°C for approximately 5 min. The cuvette was blanked and 12.5 μL of
2 mM PBD-BODIPY in 1,2,4-trichlorobenzene was added followed
by 50 μL of 0.3 M AIBN in chlorobenzene followed by thorough
mixing. After 10 min, an aliquot of the antioxidant stock solution (1
mM) in chlorobenzene was added, and the loss of absorbance at 587
nm was followed. The inhibition rate constant (kinh) and
stoichiometry (n) were determined for each experiment according
to the equations in Figure 2. Rate constants and standard derivations
are derived from three independent experiments.
Inhibited Autoxidation of Styrene at 37 °C. Styrene was
washed thrice with 1 M aqueous NaOH, dried over MgSO4, filtered,
distilled under vacuum, and purified by percolating through silica and
then basic alumina. To a cuvette containing 1.25 mL of styrene, 1.18
mL of chlorobenzene was added and the solution equilibrated for 5
min at 37 °C. The cuvette was blanked and 12.5 μL of 2 mM PBD-
BODIPY in 1,2,4-trichlorobenzene was added followed by 50 μL of
0.3 M AIBN in chlorobenzene and the solution was thoroughly
mixed. After 40 min, an aliquot of an RTA stock solution (1 mM) in
chlorobenzene was added and the loss of absorbance at 591 nm was
followed. The inhibition rate constant (kinh) and stoichiometry (n)
were determined for each experiment according to equations in
Figure 2. Kinetic data are given as averages of three independent
measurements.
Inhibited Autoxidation of 1-Hexadecene at 100 °C. 1-
Hexadecene was purified prior to autoxidations by percolating
through a column of silica and basic alumina. To a cuvette containing
0.44 mL of PhCl, 2.00 mL of 1-hexadecene was added. The cuvette
was preheated to 100 °C in a UV−vis spectrophotometer and allowed
to equilibrate for 10 min. The cuvette was blanked and PBD-BODIPY
(12.5 μL of a 2.00 mM stock solution in 1,2,4-trichlorobenzene) and
50 μL of a 50 mM stock solution of dicumyl peroxide in
chlorobenzene were added. The solution was thoroughly mixed
prior to monitoring the uninhibited co-autoxidation via the
disappearance of PBD-BODIPY. After 10 min, an aliquot of an
antioxidant stock solution in chlorobenzene was added and the loss of
absorbance at 587 nm was followed. The inhibition rate constant
(kinh) and stoichiometry (n) were determined for each experiment
according to the equations in Figure 2. Rate constants and standard
derivations are derived from three independent experiments.
Inhibited Autoxidations of n-Hexadecane at 160 °C.
Hexadecane (10 mL) was added to test tubes in a 24-place stirred-
flow reactor, thoroughly degassed with argon, and then heated to 160
°C. Once the temperature stabilized, 300 μM inhibitors and 2 mM
Primene base were added to the test tubes, and the flow of argon was
replaced with O2. An aliquot (0.1 mL) was withdrawn at regular
intervals and allowed to cool to room temperature for analysis.
Quantification of Hydroperoxides. A small volume (5 μL) of
each sample was loaded into the wells of a 96-well microplate and
diluted with 2-propanol and methanol (1:4.215 mL) using the
automated reagent dispenser of the microplate reader. Next, 30 μL of
a solution containing the fluorogenic coumarin phosphine dye (100
mM) in acetonitrile was added to each well again using the automated
reagent dispenser. The plate, incubated at 37 °C, was stirred for 30 s,
and after a 5 s delay, the fluorescence of each well was measured every
second for 60 s (excitation = 340 nm and emission = 425 nm). The
concentration of hydroperoxide in each well was determined from the
rate of phosphine oxidation using the rate constant for the reaction of
the dye with secondary hydroperoxides (k = 5.1 M−1 s−1), assuming
pseudo-first-order kinetics.
1
N5-(4-(tert-Butyl)phenyl)-N2,N2-dioctylpyrimidine-2,5-diamine (t-
Bu-2). 5.4 g, Yield: 92%. Brown oil. Mobile phase for purification:
20% Et2O/hexanes with 1% Et3N. 1H NMR (400 MHz, DMSO-d6) δ
8.17 (s, 2H), 7.38 (s, 1H), 7.18−7.09 (m, 2H), 6.65 (d, J = 8.7 Hz,
2H), 3.53−3.42 (m, 4H), 1.54 (t, J = 7.2 Hz, 4H), 1.35−1.22 (m,
20H), 1.21 (s, 9H), 0.89−0.79 (m, 6H). 13C{H} NMR (101 MHz,
DMSO-d6) δ 153.1, 126.1, 113.6, 47.6, 34.0, 31.8, 31.7, 29.3, 29.1,
27.8, 26.9, 22.5, 14.4. HRMS (EI) m/z: [M]+ calcd for C30H50N4
466.4035; found, 466.4013.
N2,N2-Dibutyl-N5-(4-neopentylphenyl)pyrimidine-2,5-diamine
(neopent-2). 1.8 g, Yield: 91%. Yellow oil. Mobile phase for
purification: 20% Et2O/hexanes with 1% Et3N. 1H NMR (400
MHz, DMSO-d6) δ 8.19 (d, J = 0.7 Hz, 2H), 7.40 (s, 1H), 6.88 (d, J =
8.4 Hz, 2H), 6.64 (d, J = 8.3 Hz, 2H), 3.57−3.42 (m, 4H), 2.32 (s,
2H), 1.59−1.48 (m, 4H), 1.29 (h, J = 7.4 Hz, 4H), 0.91 (t, J = 7.3 Hz,
7H), 0.83 (s, 9H). 13C{H} NMR (101 MHz, DMSO-d6) δ 158.3,
153.1, 144.9, 131.3, 128.9, 127.0, 113.4, 49.1, 47.4, 31.8, 30.0, 29.5,
20.1, 14.3. HRMS (EI) m/z: [M]+ calcd for C23H36N4 368.2940;
found, 368.2918.
N2,N2-Dioctyl-N5-(p-tolyl)pyrimidine-2,5-diamine (p-Me-2).
Yield: 4.8 g, 88%. Clear oil. Mobile phase for purification: 30%
Et2O/hexanes with 2% Et3N. 1H NMR (400 MHz, DMSO-d6) δ 8.16
(s, 2H), 7.36 (s, 1H), 6.93 (d, J = 8.1 Hz, 2H), 6.64 (d, J = 8.4 Hz,
2H), 3.48 (dd, J = 8.7, 6.3 Hz, 4H), 2.16 (s, 3H), 1.62−1.46 (m, 4H),
1.36−1.15 (m, 21H), 0.88−0.78 (m, 6H). 13C{H} NMR (101 MHz,
DMSO-d6) δ 152.8, 144.4, 130.0, 126.8, 114.1, 47.7, 31.7, 29.3, 29.1,
27.8, 26.9, 22.5, 20.5, 14.4. HRMS (EI) m/z: [M]+ calcd for
C27H44N4 424.3566; found, 424.3577.
N2,N2-Dioctyl-N5-(o-tolyl)pyrimidine-2,5-diamine (o-Me-2).
Yield: 1.0 g, 96%. Clear oil. Mobile phase for purification: 20%
Et2O/hexanes with 1% Et3N. 1H NMR (400 MHz, DMSO-d6) δ 8.15
(s, 2H), 7.11−7.02 (m, 1H), 6.95 (t, J = 7.7 Hz, 1H), 6.71 (s, 1H),
6.64 (td, J = 7.5, 1.1 Hz, 1H), 6.54 (d, J = 8.2 Hz, 1H), 3.49 (t, J = 7.5
Hz, 4H), 2.20 (s, 3H), 1.54 (p, J = 7.5, 7.0 Hz, 4H), 1.30−1.20 (m,
20H), 0.88−0.82 (m, 6H). 13C{H} NMR (101 MHz, DMSO-d6) δ
158.4, 154.1, 145.2, 130.9, 127.0, 126.9, 118.7, 112.5, 47.6, 31.6, 29.3,
29.1, 27.7, 26.8, 22.5, 18.2, 14.4. HRMS (EI) m/z: [M]+ calcd for
C27H44N4 424.3566; found, 424.3569.
N5-(2,4-Dimethylphenyl)-N2,N2-dihexylpyrimidine-2,5-diamine
(Me2-2). Yield: 0.9 g, 82% Brown oil. Mobile phase for purification:
20% Et2O/hexanes with 1% Et3N. 1H NMR (400 MHz, DMSO-d6) δ
8.11 (s, 2H), 6.89 (d, J = 2.0 Hz, 1H), 6.82−6.74 (m, 1H), 6.59 (s,
1H), 6.51 (d, J = 8.1 Hz, 1H), 3.48 (dd, J = 8.5, 6.4 Hz, 4H), 2.16 (d,
J = 3.4 Hz, 6H), 1.55 (d, J = 7.8 Hz, 4H), 1.33−1.19 (m, 12H), 0.91−
0.78 (m, 6H). 13C{H} NMR (101 MHz, DMSO-d6) δ 158.2, 153.0,
142.5, 131.7, 127.7, 127.6, 127.3, 124.9, 113.6, 47.6, 31.6, 27.8, 26.6,
22.5, 20.5, 18.2, 14.3. HRMS (EI) m/z: [M]+ calcd for C24H38N4
382.3096; found, 382.3073.
N2,N2-Dihexyl-N5-mesitylpyrimidine-2,5-diamine (mes-2). Yield:
0.8 g, 72% Brown oil. Mobile phase for purification: 20% Et2O/
1
hexanes with 1% Et3N. H NMR (400 MHz, DMSO-d6) δ 7.61 (s,
2H), 6.89 (s, 2H), 6.62 (s, 1H), 3.44−3.35 (m, 4H), 2.22 (s, 3H),
2.08 (s, 7H), 1.53−1.40 (m, 4H), 1.24 (s, 13H), 0.84 (q, J = 5.0, 3.5
Hz, 6H). 13C{H} NMR (101 MHz, DMSO-d6) δ 156.4, 144.2, 136.6,
134.4, 133.9, 132.1, 129.5, 47.6, 31.6, 27.9, 26.6, 22.5, 20.9, 18.4, 14.3.
HRMS (EI) m/z: [M]+ calcd for C25H40N4 396.3253; found,
396.3270.
N2,N2-Dioctyl-N5-(4-(methyl-d3)phenyl-)pyrimidine-2,5-diamine
(d3-p-Me-2). Yield: 0.2 g, 34% Brown oil. Mobile phase for
purification: 30% Et2O/hexanes with 2% Et3N. 1H NMR (400
MHz, DMSO-d6) δ 8.17 (s, 2H), 7.37 (s, 1H), 6.94 (d, J = 8.4 Hz,
Quantification of Diarylamine Consumption. A small volume
(5 μL) of each sample was loaded into the wells of a 96-well
microplate and diluted with 2-propanol and methanol (1:4.215 mL)
6548
J. Org. Chem. 2021, 86, 6538−6550